Hosted by:

In partnership with:
![]()
With sponsorship support from:

EL-PFDD Meeting on GSD1a
On October 9, 2025, The Children's Fund for GSD Research hosted an Externally Led Patient Focused Drug Development Meeting (EL-PFDD). This meeting gave patients and families an opportunity to share their voices and stories with the purpose of accelerating research and improving care.
EL-PFDD meetings give the Food and Drug Administration (FDA) and other key stakeholders - including researchers, biopharma companies, healthcare providers, federal regulatory partners, and the general public - an important opportunity to hear directly from patients, their families, caregivers, and patient advocates about the symptoms that matter most to them, the impact the disease has on patients' daily lives, patients' experiences with currently available treatments, and patient's priorities for therapeutic outcomes.
Agenda & Speakers
- 10:00AM - 10:05AM
-
Opening Remarks / Welcome
Meredith Gussin & Lisa Hodes
Board of Directors
The Children's Fund for GSD Research
- 10:05AM - 10:15AM
-
FDA Opening Remarks
Jemila Venner-Walcott, MD, Office of Therapeutic Products,
Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
- 10:15AM - 10:30AM
-
Clinical Overview of GSD1a
David Rodriguez-Buritica, MD, Geneticist/Endocrinologist and
Co-Director of Glycogen Storage Disease Clinic at University of Texas at Health Science Center
- 10:30AM - 10:35AM
-
Introduction & Meeting Overview
James Valentine, JD, MHS, Meeting Moderator
- 10:35AM - 10:45AM
-
Demographic Polling
James Valentine, MD, MHS, Meeting Moderator
- 10:45AM - 11:10AM
-
Patient / Caregiver Panel - Living with GSD1a
A panel of 5 Patients and Caregivers will provide comments to start the discussion on
the symptoms and daily impact of living with GSD1a.
- 11:10AM - 12:30PM
-
Large Group Faciliated Discussion
Facilitated by Meredith Gussin and James Valentine
Patients and Caregivers in the audience are invited to add to the dialogue.
- 12:30 PM - 1:00 PM
- Break
- 1:00 PM - 1:10 PM
-
Treatment of GSD1a: An Overview
Rebecca Riba-Wolman, MD, Pediatric Endocrinologist,
Director of Glycogen Storage Disease Program & Disorders of Hypoglycemia at Connecticut Children’s
- 1:10 PM - 1:35 PM
-
Patient / Caregiver Panel - Current and Future Treatments for GSD1a
A panel of 5 Patients and Caregivers will provide comments to start the discussion on
GSD1a treatments and treatment experiences.
- 1:35 PM - 2:45 PM
-
Large-Group Facilitated Discussion
Facilitated by Meredith Gussin and James Valentine
Patients and Caregivers in the audience are invited to add to the dialogue.
- 2:45 PM - 2:55 PM
-
Meeting Summary
Sarah Wicks, JD, MPH
Hyman, Phelps, & McNamara, P.C.
- 2:55 PM - 3:00 PM
-
Closing Remarks
Meredith Gussin
Board of Directors
The Children's Fund for GSD Research
Community Webinar PFDD Q&A
In this Community Webinar, James Valentine and Sarah Wicks of Hyman Phelps McNamara helped families unterstand the drug development process, the role of the FDA and what to expect during the Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting where we informed the U.S. Food and Drug Administration (FDA) and other stakeholders about the patient and caregiver perspectives on living with GSD1a.
This template controls the elements:
FOOTER: Footer Title, Footer Descriptions
CUSTOM MENU: Images and columns into header main menu submenu items
* This message is only visible in administrative mode
The Children's Fund for
Glycogen Storage Disease Research
20 Sherwood Lane
Cheshire, CT 06410
" ... because every child deserves to be healthy."